Activininsights Joins Prestigious UK Digital Health Playbook
We are delighted to share the exciting news that Activininsights has earned its place in the esteemed Department for Business and Trade's newly enhanced Digital Health Playbook!
About the Digital Health Playbook:
Featuring a robust lineup of over 180 UK innovators and exporters, the Digital Health Playbook serves as the ultimate resource hub for healthtech innovation. This inclusive platform showcases specialists with vast expertise in delivering advanced patient care, insights and analysis, core infrastructure, and self-care solutions.
Rigorous Selection Process:
We underwent a meticulous selection process, our inclusion in the Playbook is a testament to our collaborative excellence within healthcare, our responsiveness, and our role in representing the UK's journey in digital health, particularly within the NHS. The Playbook undergoes regular reviews to ensure its cutting-edge relevance.
Find us under "Driving insights and analysis" within the Playbook if you seek a partner proficient in delivering intelligence derived from healthcare data.
How Activininsights Stands Out:
As a distinguished digital health company, we specialise in objectively measuring physical behaviours and lifestyles. Our technologies, deployed worldwide in clinical trials, health management, and research markets, provide accurate and continuous monitoring of lifestyle beyond clinical settings. Key features include:
Privacy-by-design data infrastructures
Rigorous open protocols for secure and transparent management of sensitive behavioural information
GENEActiv: Lightweight, waterproof raw data accelerometer designed for public health research and clinical trials to medical-grade standards.
Activinsights Band: Low-burden, continuous assessment tool with wireless data transfers for up to a year, utilised in over 800+ peer-reviewed publications worldwide.
Successes in the UK/NHS: Deployed in the NHS, UK, and global academic public health research sectors, supporting researchers and healthcare practitioners with objective physical activity and sleep data.
Join our journey in shaping the future of digital health! Let's collaborate on upcoming research or clinical trials—contact us today for impactful partnerships.
Activinsights Welcomes James and Emily to the team
Activinsights proudly introduces its latest team members, Emily Lawrence and James Nelson, marking a significant milestone amid a year of remarkable growth for the company. This expansion not only reflects Activinsights' enduring success but also heralds a new era of possibilities, as the addition of Emily and James positions us to advance our presence in the dynamic arena of clinical trials.
James Nelson Data Manager
James steps in as our new Data Manager, bringing a profound understanding of data intricacies to the team.
James will be a guiding force behind our data initiatives, ensuring our data is meticulously managed.
Emily Joins us as Marketing Manager, bringing a wealth of expertise in the world of marketing.
Her passion for creative strategies and commitment to achieving outstanding results make Emily a perfect fit for our innovative team.
Activinsights Attains Coveted ISO 27001 Certification
Activinsights Attains Coveted ISO 27001 Certification, Demonstrating Commitment to Information Security Excellence.
Activinsights, a market leader in the remote monitoring of clinical trial participants, proudly announces its successful achievement of ISO 27001 certification, solidifying its dedication to ensuring the highest standards of information security and data protection.
ISO 27001 is an internationally recognised standard that establishes stringent requirements for the establishment, implementation, maintenance, and continuous improvement of an information security management system. Achieving this certification demonstrates Activinsights commitment to safeguarding sensitive medical data, ensuring it confidentiality, integrity, and availability, whilst mitigating risk.
Activinsights has undertaken an extensive audit process to validate its adherence to the ISO 27001 Standards. This accomplishment showcases the company’s proactive approach to mitigating security risks, bolstering client trust, and aligning with global best practices.
As digital health measurement experts, Activinsights handle, process, and report significant amounts of data that are used to enhance public health, advance pharmaceutical drug development, and manage diseases. The implementation of an ISO 27001 compliant Information Security Management System signifies their continuous assessment of risks linked to data in the contemporary world. This effort aims to provide clients, partners, and participants with the assurance that their data will remain secure, protected, and accessible whenever needed.
Obtaining the ISO 27001 is a remarkable achievement that underscores our dedication to ensuring the utmost security for our client's valuable data” said Matt Jones, Quality Manager at Activinsights. “Our team has worked diligently to implement and maintain robust information security protocols, and this certification is a testament to their hard work and expertise.”
By achieving ISO 27001 certification, Activinsights confirms its position as a trusted partner for clients needing the highest levels of data security. This certification serves as an assurance that the company has put in place comprehensive measures to identify and mitigate potential security vulnerabilities, protect against data breaches, and maintain compliance with industry regulations.
Activinsights is a digital health company that specialises in the objective measurement of physical behaviours and lifestyle. Our technologies are used worldwide within the clinical trials, health management and research markets to provide accurate and continuous monitoring of lifestyle outside of the clinic environment. We develop novel health measures from data collected by our own professional wearables and other connected devices, such as phone apps, within a scalable global and secure infrastructure. Advanced data analytics reveal insights, novel endpoints and biomarkers that support pharmaceutical drug development, clinical practice, and disease management. Find out more at www.activinsights.com.
For more information, contact:
Raghbir Bains PhD
Commercial Director, Activinsights firstname.lastname@example.org
+44 (0)7496 292 073
Activinsights announce a solution for all Actiwatch users
Activinsights are pleased to announce an instant solution for all sleep and Actiwatch users.
Sleep researchers, clinicians and practitioners can now collect high resolution raw data from the GENEActiv and continue to use the Actiware software for analysis. Activinsights are releasing the capability to turn the GENEActiv .bin files into .AWD files. These .AWD files can then be entered into the existing Actiware software for users to continue to generate double plotted sleep graphs and manipulate data in the way they have always been used to.
The GENEActiv .bin file to .AWD files conversion is an instant solution for anyone interested in objective sleep measurement with actigraphy and beyond. Furthermore, the collection of high-resolution, raw data with the GENEActiv provides users with the additional benefit of future proofing the data set collected. This enables researchers to continue to apply novel analysis techniques to the unfiltered raw data in the future, removes any limitations against black-box algorithms and increases the value of the data collected for future research capabilities. The GENEActiv provides backward capability with Actiware and enables users to use any system going forward.
Digital Health is rightly seen as the answer to many of the challenges facing global healthcare. The role of digital technology in realising the dream of accessible, affordable, and sustainable care has grown across the entire range of health economies in not only serving current needs, but in building the basis for the healthcare of the future: personalised, digital by default and truly patient centric.
The innovations highlighted in the Playbook can offer support to healthcare in a variety of ways from solutions such as from Activinsights to support people at home with self-care apps and wearable technology which all will help transform healthcare, particularly as the Covid-19 pandemic has demonstrated the tremendous potential of digital transformation.
Activinsights is featured under the Remote and Virtual Care category, the wearable technology enabling to monitor patients remotely and maintaining the ability to act fast. These digital technology solutions are interventions that can be initiated by a physician and linked to a clinical care pathway. It differs from self-care solutions, which are driven by the empowered citizen. This a UK solution which allows healthcare providers to reduce risk, cost, and readmissions and demands on your health system, while improving the patient experience, by empowering teams to safely monitor, manage and engage patients at home.
Activinsights is a digital health company that specialises in the objective measurement of physical behaviours and lifestyle. Our technologies are used worldwide within the clinical trials, health management and research markets to provide accurate and continuous monitoring of lifestyle outside of the clinic environment. We develop novel health measures from data collected by our own professional wearables within a scalable global and secure infrastructure.
Did you know that the use of selection biomarkers in clinical development improves the success rate in every phase (I-III)? And that use of selection biomarkers improves the overall success from Phase I through regulatory approval more than 3-fold? Examples include using tumour markers to select patients for cancer therapy trials or knowing the ejection fraction (EF) for heart failure patients since those with preserved EF behave and respond differently from those with reduced EF.
Unfortunately, many patient selection processes are dependent on an overarching inclusive diagnosis, a subjective rating scale or both. These are opportunities for the use of actigraphy to objectively and precisely characterize the functional status of study candidates. Oncology, neurodegenerative diseases, and many others depend on subjective rating scales for patient selection. For example, oncology subjects are often selected based on an the Eastern Cooperative Oncology Score (ECOG) score.
This score characterizes the ability of a subject to perform daily activities and any restrictions in place. Clinical development studies often select ECOG subjects judged to be ECOG 0, 1 or 2 to ensure that a subject is able to tolerate the study therapy. But performance and functional data from wearable technologies show that what were thought to be homogeneous [ECOG] groups with a given score, in actuality are groups that demonstrate significantly heterogeneity in their total activity, step counts, stairs climbed and other actigraphy metrics.
It is time to consider true functional status as a digital biomarker of patients’ suitability for a given trial. Given the benefit of using selection biomarkers in clinical development, the development and application of digital selection biomarkers through use of wearable sensors and functional assessment in real-world settings could significantly improve both the efficiency and success of clinical development trials. This is especially true in conditions where the selection of study subjects is based on broad diagnosis, subjective classification, surveys and patient-reported outcomes.